Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1975 1
1981 1
1983 1
1984 1
1986 4
1987 4
1988 2
1989 2
1990 1
1991 5
1992 2
1993 3
1995 3
1996 1
1997 3
1998 2
1999 5
2000 4
2001 5
2002 5
2003 2
2004 6
2005 8
2006 5
2007 3
2008 7
2009 9
2010 12
2011 6
2012 12
2013 9
2014 11
2015 27
2016 22
2017 19
2018 23
2019 27
2020 32
2021 14
Text availability
Article attribute
Article type
Publication date

Search Results

276 results
Results by year
Filters applied: . Clear all The following terms were ignored: %, %, %, %, %, % The following terms were not found in PubMed: 23x000f8, 3Bhn, 20SK, 5BAuthor
Page 1
The effect of massage therapy and/or exercise therapy on subacute or long-lasting neck pain--the Stockholm neck trial (STONE): study protocol for a randomized controlled trial.
Skillgate E, Bill AS, Côté P, Viklund P, Peterson A, Holm LW. Skillgate E, et al. Trials. 2015 Sep 16;16:414. doi: 10.1186/s13063-015-0926-4. Trials. 2015. PMID: 26377322 Free PMC article. Clinical Trial.
METHODS/DESIGN: A randomized controlled trial in which at least 600 study participants with subacute or long-lasting nonspecific neck pain will be recruited and randomly allocated to one of four treatment arms: massage therapy (A), exercise therapy (B), exercise therapy pl …
METHODS/DESIGN: A randomized controlled trial in which at least 600 study participants with subacute or long-lasting nonspecific neck pain w …
Screw Fixation Versus Hemiarthroplasty for Nondisplaced Femoral Neck Fractures in Elderly Patients: A Multicenter Randomized Controlled Trial.
Dolatowski FC, Frihagen F, Bartels S, Opland V, Šaltytė Benth J, Talsnes O, Hoelsbrekken SE, Utvåg SE. Dolatowski FC, et al. J Bone Joint Surg Am. 2019 Jan 16;101(2):136-144. doi: 10.2106/JBJS.18.00316. J Bone Joint Surg Am. 2019. PMID: 30653043 Clinical Trial.
Assessors blinded to the type of treatment evaluated hip function with the Harris hip score (HHS) as the primary outcome as well as on the basis of mobility assessed with the timed "Up & Go" (TUG) test, pain as assessed on a numerical rating scale, and quality of life as asse …
Assessors blinded to the type of treatment evaluated hip function with the Harris hip score (HHS) as the primary outcome as well as on the b …
Which Is the Best Outcome Measure for Rotator Cuff Tears?
Dabija DI, Pennings JS, Archer KR, Ayers GD, Higgins LD, Kuhn JE, Baumgarten KM, Matzkin E, Jain NB. Dabija DI, et al. Clin Orthop Relat Res. 2019 Aug;477(8):1869-1878. doi: 10.1097/CORR.0000000000000800. Clin Orthop Relat Res. 2019. PMID: 31335605 Free PMC article.
QUESTIONS/PURPOSES: Our objective was to determine psychometric properties (reliability, convergent and discriminant validity, and responsiveness) of five commonly used outcome instruments (the ASES, the SPADI, the quickDASH, the SF-12, and the EuroQol-5D) in a longitudina …
QUESTIONS/PURPOSES: Our objective was to determine psychometric properties (reliability, convergent and discriminant validity, and responsiv …
Ibrutinib for patients with rituximab-refractory Waldenström's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial.
Dimopoulos MA, Trotman J, Tedeschi A, Matous JV, Macdonald D, Tam C, Tournilhac O, Ma S, Oriol A, Heffner LT, Shustik C, García-Sanz R, Cornell RF, de Larrea CF, Castillo JJ, Granell M, Kyrtsonis MC, Leblond V, Symeonidis A, Kastritis E, Singh P, Li J, Graef T, Bilotti E, Treon S, Buske C; iNNOVATE Study Group and the European Consortium for Waldenström's Macroglobulinemia. Dimopoulos MA, et al. Lancet Oncol. 2017 Feb;18(2):241-250. doi: 10.1016/S1470-2045(16)30632-5. Epub 2016 Dec 10. Lancet Oncol. 2017. PMID: 27956157 Clinical Trial.
A clinically meaningful improvement from baseline in FACT-An score, anaemia subscale score, and the EQ-5D-5L were reported at all post-baseline visits. Time to next treatment will be presented at a later date. ...Five (16%) patients discontinued ibrutinib: three due to pro …
A clinically meaningful improvement from baseline in FACT-An score, anaemia subscale score, and the EQ-5D-5L were reported at all pos …
Impact of lanadelumab on health-related quality of life in patients with hereditary angioedema in the HELP study.
Lumry WR, Weller K, Magerl M, Banerji A, Longhurst HJ, Riedl MA, Lewis HB, Lu P, Devercelli G, Jain G, Maurer M; HELP Study Investigators. Lumry WR, et al. Allergy. 2021 Apr;76(4):1188-1198. doi: 10.1111/all.14680. Epub 2020 Dec 24. Allergy. 2021. PMID: 33258114
The generic EQ-5D-5L questionnaire was administered on days 0, 98, and 182. Comparisons were made between placebo and (a) all lanadelumab-treated patients and (b) individual lanadelumab groups for changes in scores (day 0-182) and proportions achieving the minimal c …
The generic EQ-5D-5L questionnaire was administered on days 0, 98, and 182. Comparisons were made between placebo and (a) all lanadel …
Oral versus intramuscular administration of vitamin B12 for the treatment of patients with vitamin B12 deficiency: a pragmatic, randomised, multicentre, non-inferiority clinical trial undertaken in the primary healthcare setting (Project OB12).
Sanz-Cuesta T, González-Escobar P, Riesgo-Fuertes R, Garrido-Elustondo S, del Cura-González I, Martín-Fernández J, Escortell-Mayor E, Rodríguez-Salvanés F, García-Solano M, González-González R, Martín-de la Sierra-San Agustín MÁ, Olmedo-Lucerón C, Sevillano Palmero ML, Mateo-Ruiz C, Medina-Bustillo B, Valdivia-Pérez A, García-de Blas-González F, Mariño-Suárez JE, Rodríguez-Barrientos R, Ariza-Cardiel G, Cabello-Ballesteros LM, Polentinos-Castro E, Rico-Blázquez M, Rodríguez-Monje MT, Soto-Díaz S, Martín-Iglesias S, Rodríguez-González R, Bretón-Lesmes I, Vicente-Herrero M, Sánchez-Díaz J, Gómez-Gascón T, Drake-Canela M, Asúnsolo-del Barco Á; OB12 Group. Sanz-Cuesta T, et al. BMC Public Health. 2012 May 31;12:394. doi: 10.1186/1471-2458-12-394. BMC Public Health. 2012. PMID: 22650964 Free PMC article. Clinical Trial.
The main outcome variable to be monitored in both treatment arms is the normalisation of the serum vitamin B12 concentration at weeks 8, 26 and 52; the secondary outcome variables include the serum concentration of vitamin B12 (in pg/ml), adherence to treatment, quality of …
The main outcome variable to be monitored in both treatment arms is the normalisation of the serum vitamin B12 concentration at weeks 8, …
Adhesive capsulitis of the shoulder: protocol for the adhesive capsulitis biomarker (AdCaB) study.
Page RS, McGee SL, Eng K, Brown G, Beattie S, Collier F, Gill SD. Page RS, et al. BMC Musculoskelet Disord. 2019 Apr 5;20(1):145. doi: 10.1186/s12891-019-2536-x. BMC Musculoskelet Disord. 2019. PMID: 30953551 Free PMC article.
Clinical outcomes regarding pain, function and quality of life will be assessed using the Oxford Shoulder Score, Oxford Shoulder Instability Score, Quick DASH, American Shoulder and Elbow Society Score, EQ-5D-5 L and active shoulder range of movement. Clinical outcomes wil …
Clinical outcomes regarding pain, function and quality of life will be assessed using the Oxford Shoulder Score, Oxford Shoulder Instability …
Patient-reported quality of life in patients with relapsed/refractory cutaneous T-cell lymphoma: Results from the randomised phase III ALCANZA study.
Dummer R, Prince HM, Whittaker S, Horwitz SM, Kim YH, Scarisbrick J, Quaglino P, Zinzani PL, Wolter P, Eradat H, Pinter-Brown L, Sanches JA, Ortiz-Romero PL, Akilov OE, Geskin L, Huen A, Walewski J, Wang Y, Lisano J, Richhariya A, Feliciano J, Zhu Y, Bunn V, Little M, Zagadailov E, Dalal MR, Duvic M. Dummer R, et al. Eur J Cancer. 2020 Jul;133:120-130. doi: 10.1016/j.ejca.2020.04.010. Epub 2020 Jun 2. Eur J Cancer. 2020. PMID: 32502876 Free article. Clinical Trial.
METHODS: QoL measures in ALCANZA were based on the Skindex-29, Functional Assessment of Cancer Therapy-General (FACT-G) and European QoL 5-dimension (EQ-5D) questionnaires. RESULTS: Mean maximum reduction from the baseline Skindex-29 symptom domain score (key secondary end …
METHODS: QoL measures in ALCANZA were based on the Skindex-29, Functional Assessment of Cancer Therapy-General (FACT-G) and European QoL 5-d …
Peruvian Valuation of the EQ-5D-5L: A Direct Comparison of Time Trade-Off and Discrete Choice Experiments.
Augustovski F, Belizán M, Gibbons L, Reyes N, Stolk E, Craig BM, Tejada RA. Augustovski F, et al. Value Health. 2020 Jul;23(7):880-888. doi: 10.1016/j.jval.2020.05.004. Epub 2020 Jul 18. Value Health. 2020. PMID: 32762989
All respondents completed a DCE, including 10 latent-scale pairs (A/B) with 5 EQ-5D-5L attributes, and 12 matched pairs (A/B and B/C) with 5 EQ-5D-5L and one lifespan attributes. ...CONCLUSIONS: Besides producing EQ-5D-5L value sets for P …
All respondents completed a DCE, including 10 latent-scale pairs (A/B) with 5 EQ-5D-5L attributes, and 12 matched pairs (A/ …
Quality of life after pelvic ring fractures: A cross-sectional study.
Brouwers L, Lansink KWW, de Jongh MAC. Brouwers L, et al. Injury. 2018 Apr;49(4):812-818. doi: 10.1016/j.injury.2018.03.012. Epub 2018 Mar 14. Injury. 2018. PMID: 29566985
RESULTS: EQ-5D: The mean EQ-5D Visual Analogue Scale (VAS) for Tiles A-C was, respectively, 74 (SD 18), 74 (SD 19) and 67 (SD 21), and the mean EQ-5D index score was, respectively, 0.81 (SD 0.23), 0.77 (SD 0.30) and 0.71 (SD 0.26). ...CONCLUSIONS: In c …
RESULTS: EQ-5D: The mean EQ-5D Visual Analogue Scale (VAS) for Tiles A-C was, respectively, 74 (SD 18), 74 (SD 19) and 67 (SD …
276 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page